Celularity Inc. vs Regenxbio Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Regenxbio Inc. is the larger company by market value: $513 M against $28 M for Celularity Inc., 19 times as much (market caps of Oct 30, 2026 for Celularity Inc. and Oct 6, 2026 for Regenxbio Inc.).
- Regenxbio Inc. had more revenue: $170 M against $27 M for Celularity Inc., both in the year to December 2025.
- Both made a net loss: $92 M for Celularity Inc. and $194 M for Regenxbio Inc.
- Regenxbio Inc. keeps more of each dollar of sales: a net margin of -113.8% against -345.5% for Celularity Inc.
- Regenxbio Inc. employs more people: 372 against 288 at Celularity Inc. Each employee brings in about $92,188 of revenue at Celularity Inc. and $458,172 at Regenxbio Inc.
- Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against -51.0% for Celularity Inc.
- Both are in the distress zone of the Altman Z-score.
Market value, the same start = 100
From Jan 2022: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Celularity Inc. CELU · #23,327 in the world | Regenxbio Inc. RGNX · #12,428 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $28 M | $513 M |
| Revenue | $27 M | $170 M |
| Net income | $-92 M▲ best | $-194 M |
| Employees | 288 | 372 |
| Valuation | ||
| Price to sales | 1.5× | 3.3× |
| Price to book | — | 5.0× |
| Free cash flow yield | -23.8%▲ best | -24.6% |
| Profitability | ||
| Gross margin | 24.4% | — |
| Operating margin | -230.9% | -94.6%▲ best |
| Net margin | -345.5% | -113.8%▲ best |
| Return on equity | — | -107.0% |
| Growth | ||
| Revenue growth | -51.0% | 104.5%▲ best |
| Revenue growth, 3 years a year | 13.9% | 14.8%▲ best |
| Cash | ||
| Free cash flow margin | — | -74.1% |
| Altman Z-score zone | distress | distress |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Celularity Inc. or Regenxbio Inc.?
Regenxbio Inc. is the larger company by market value: $513 M against $28 M for Celularity Inc., 19 times as much (market caps of Oct 30, 2026 for Celularity Inc. and Oct 6, 2026 for Regenxbio Inc.).
Which makes more money, Celularity Inc. or Regenxbio Inc.?
Regenxbio Inc. had more revenue: $170 M against $27 M for Celularity Inc., both in the year to December 2025. Both made a net loss: $92 M for Celularity Inc. and $194 M for Regenxbio Inc.
Which is more profitable, Celularity Inc. or Regenxbio Inc.?
Regenxbio Inc. keeps more of each dollar of sales: a net margin of -113.8% against -345.5% for Celularity Inc.
Which has more employees, Celularity Inc. or Regenxbio Inc.?
Regenxbio Inc. employs more people: 372 against 288 at Celularity Inc. Each employee brings in about $92,188 of revenue at Celularity Inc. and $458,172 at Regenxbio Inc.
Which is growing faster, Celularity Inc. or Regenxbio Inc.?
Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against -51.0% for Celularity Inc.
Which is financially stronger, Celularity Inc. or Regenxbio Inc.?
Both are in the distress zone of the Altman Z-score.
More about Celularity Inc.
More about Regenxbio Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.